C120H138FN41O9S — CID 162206024
(E)-5-(dimethylamino)-1-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]pent-3-en-2-one;2-[4-[(2-ethenylimidazol-1-yl)methyl]phenoxy]-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;2-[4-(3-fluoro-1,2-oxazol-5-yl)phenoxy]-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;(E)-1-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]but-2-en-1-one;5-[[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]methyl]-3-oxo-1,2-thiazole-4-carbonitrile (PubChem CID 162206024) has the molecular formula C120H138FN41O9S and a molecular weight of 2349.77 g/mol. Its IUPAC name is (E)-5-(dimethylamino)-1-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]pent-3-en-2-one;2-[4-[(2-ethenylimidazol-1-yl)methyl]phenoxy]-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;2-[4-(3-fluoro-1,2-oxazol-5-yl)phenoxy]-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;(E)-1-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]but-2-en-1-one;5-[[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]methyl]-3-oxo-1,2-thiazole-4-carbonitrile.
| Compound Name | (E)-5-(dimethylamino)-1-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]pent-3-en-2-one;2-[4-[(2-ethenylimidazol-1-yl)methyl]phenoxy]-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;2-[4-(3-fluoro-1,2-oxazol-5-yl)phenoxy]-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;(E)-1-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]but-2-en-1-one;5-[[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]methyl]-3-oxo-1,2-thiazole-4-carbonitrile |
|---|---|
| PubChem CID | 162206024 |
| Molecular Formula | C120H138FN41O9S |
| Molecular Weight | 2349.77 g/mol |
| Exact Mass | 2348.13 |
| IUPAC Name | (E)-5-(dimethylamino)-1-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]pent-3-en-2-one;2-[4-[(2-ethenylimidazol-1-yl)methyl]phenoxy]-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;2-[4-(3-fluoro-1,2-oxazol-5-yl)phenoxy]-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;(E)-1-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]but-2-en-1-one;5-[[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]oxyphenyl]methyl]-3-oxo-1,2-thiazole-4-carbonitrile |
| SMILES | C/C=C/C(=O)c1ccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1.C=Cc1nccn1Cc1ccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1.Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccc(-c4cc(F)no4)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccc(CC(=O)/C=C/CN(C)C)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccc(Cc4s[nH]c(=O)c4C#N)cc3)n2)n[nH]1 |
| InChI | InChI=1S/C26H34N8O2.C25H29N9O.C24H25N9O2S.C23H27N7O2.C22H23FN8O2/c1-19-16-24(31-30-19)27-23-18-25(34-14-12-33(4)13-15-34)29-26(28-23)36-22-9-7-20(8-10-22)17-21(35)6-5-11-32(2)3;1-4-23-26-9-10-34(23)17-19-5-7-20(8-6-19)35-25-28-21(27-22-15-18(2)30-31-22)16-24(29-25)33-13-11-32(3)12-14-33;1-15-11-21(30-29-15)26-20-13-22(33-9-7-32(2)8-10-33)28-24(27-20)35-17-5-3-16(4-6-17)12-19-18(14-25)23(34)31-36-19;1-4-5-19(31)17-6-8-18(9-7-17)32-23-25-20(24-21-14-16(2)27-28-21)15-22(26-23)30-12-10-29(3)11-13-30;1-14-11-20(28-27-14)24-19-13-21(31-9-7-30(2)8-10-31)26-22(25-19)32-16-5-3-15(4-6-16)17-12-18(23)29-33-17/h5-10,16,18H,11-15,17H2,1-4H3,(H2,27,28,29,30,31);4-10,15-16H,1,11-14,17H2,2-3H3,(H2,27,28,29,30,31);3-6,11,13H,7-10,12H2,1-2H3,(H,31,34)(H2,26,27,28,29,30);4-9,14-15H,10-13H2,1-3H3,(H2,24,25,26,27,28);3-6,11-13H,7-10H2,1-2H3,(H2,24,25,26,27,28)/b6-5+;;;5-4+; |
| InChIKey | ZSEUBXCQKLEODZ-ISZRGPFOSA-N |
| XLogP | 16.86 |
| TPSA | 548.88 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 45 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2349.77 |
| LogP ≤ 5 | 16.86 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 45 |
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|